Tarbox Family Office, Inc. Sarepta Therapeutics, Inc. Transaction History

Tarbox Family Office, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 16, 2021	SELL	$69.38 - $86.75 $832 - $1,041	-12 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$72.25 - $168.95 $216 - $506	3 Added 33.33%	12 $1,000
Q2 2020 Jul 23, 2020	SELL	$93.0 - $171.7 $651 - $1,201	-7 Reduced 43.75%	9 $1,000
Q1 2020 Apr 30, 2020	BUY	$82.38 - $131.64 $741 - $1,184	9 Added 128.57%	16 $2,000
Q4 2019 Jan 31, 2020	BUY	$76.53 - $135.58 $535 - $949	7 New	7 $1,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.6B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.